{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T14:51:18Z","timestamp":1782226278989,"version":"3.54.5"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14420-5","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T10:00:46Z","timestamp":1749031246000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Hepatitis B and C virus infection and risk of multiple myeloma: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-8204-3232","authenticated-orcid":false,"given":"Kamran","family":"Zamani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poorya","family":"Rostami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4494-4380","authenticated-orcid":false,"given":"Ramyar Rahimi","family":"Darehbagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7516-5131","authenticated-orcid":false,"given":"Maryam","family":"Afraie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2936-5930","authenticated-orcid":false,"given":"Yousef","family":"Moradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,4]]},"reference":[{"issue":"2","key":"14420_CR1","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3322\/CA.2007.0010","volume":"58","author":"A Jemal","year":"2008","unstructured":"Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58(2):71\u201396.","journal-title":"CA Cancer J Clin"},{"issue":"18","key":"14420_CR2","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1056\/NEJMra041875","volume":"351","author":"RA Kyle","year":"2004","unstructured":"Kyle RA, Rajkumar SV. Multiple myeloma. N Engl J Med. 2004;351(18):1860\u201373.","journal-title":"N Engl J Med"},{"issue":"5","key":"14420_CR3","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/0002-9343(78)90522-3","volume":"64","author":"RA Kyle","year":"1978","unstructured":"Kyle RA. Monoclonal gammopathy of undetermined significance. Natural history in 241 cases. Am J Med. 1978;64(5):814\u201326.","journal-title":"Am J Med"},{"issue":"10","key":"14420_CR4","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1038\/leu.2009.134","volume":"23","author":"O Landgren","year":"2009","unstructured":"Landgren O, Weiss BM. Patterns of monoclonal gammopathy of undetermined significance and multiple myeloma in various ethnic\/racial groups: support for genetic factors in pathogenesis. Leukemia. 2009;23(10):1691\u20137.","journal-title":"Leukemia"},{"issue":"25","key":"14420_CR5","doi-asserted-by":"publisher","first-page":"6386","DOI":"10.1182\/blood-2009-02-203471","volume":"113","author":"O Landgren","year":"2009","unstructured":"Landgren O, Kyle RA, Hoppin JA, Beane Freeman LE, Cerhan JR, Katzmann JA, et al. Pesticide exposure and risk of monoclonal gammopathy of undetermined significance in the agricultural health study. Blood. 2009;113(25):6386\u201391.","journal-title":"Blood"},{"issue":"12","key":"14420_CR6","doi-asserted-by":"publisher","first-page":"Itc177","DOI":"10.7326\/AITC202212200","volume":"175","author":"WI Gonsalves","year":"2022","unstructured":"Gonsalves WI, Rajkumar SV. Monoclonal gammopathy of undetermined significance. Ann Intern Med. 2022;175(12):Itc177\u201392.","journal-title":"Ann Intern Med"},{"issue":"2","key":"14420_CR7","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/j.1600-0609.2004.00376.x","volume":"74","author":"S Takai","year":"2005","unstructured":"Takai S, Tsurumi H, Ando K, Kasahara S, Sawada M, Yamada T, et al. Prevalence of hepatitis B and C virus infection in haematological malignancies and liver injury following chemotherapy. Eur J Haematol. 2005;74(2):158\u201365.","journal-title":"Eur J Haematol"},{"issue":"6","key":"14420_CR8","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1053\/jhep.2003.50220","volume":"37","author":"AL Cheng","year":"2003","unstructured":"Cheng AL, Hsiung CA, Su IJ, Chen PJ, Chang MC, Tsao CJ, et al. Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma. Hepatology. 2003;37(6):1320\u20138.","journal-title":"Hepatology"},{"issue":"4","key":"14420_CR9","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cld.2016.06.005","volume":"20","author":"RM Kwok","year":"2016","unstructured":"Kwok RM, Tran TT. Hepatitis B and risk of Non-Hepatocellular carcinoma malignancy. Clin Liver Dis. 2016;20(4):693\u2013702.","journal-title":"Clin Liver Dis"},{"issue":"19","key":"14420_CR10","doi-asserted-by":"publisher","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","volume":"117","author":"E Campo","year":"2011","unstructured":"Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood. 2011;117(19):5019\u201332.","journal-title":"Blood"},{"issue":"9","key":"14420_CR11","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1111\/j.1349-7006.2004.tb03256.x","volume":"95","author":"K Matsuo","year":"2004","unstructured":"Matsuo K, Kusano A, Sugumar A, Nakamura S, Tajima K, Mueller NE. Effect of hepatitis C virus infection on the risk of non-Hodgkin\u2019s lymphoma: a meta-analysis of epidemiological studies. Cancer Sci. 2004;95(9):745\u201352.","journal-title":"Cancer Sci"},{"issue":"11","key":"14420_CR12","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1158\/1055-9965.EPI-06-0308","volume":"15","author":"L Dal Maso","year":"2006","unstructured":"Dal Maso L, Franceschi S. Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies. Cancer Epidemiol Biomarkers Prev. 2006;15(11):2078\u201385.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"8","key":"14420_CR13","first-page":"883","volume":"85","author":"M Montella","year":"2000","unstructured":"Montella M, Crispo A, Russo F, Ronga D, Tridente V, Tamburini M. Hepatitis C virus infection and new association with extrahepatic disease: multiple myeloma. Haematologica. 2000;85(8):883\u20134.","journal-title":"Haematologica"},{"issue":"2","key":"14420_CR14","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/BF03032580","volume":"7","author":"S Gharagozloo","year":"2001","unstructured":"Gharagozloo S, Khoshnoodi J, Shokri F. Hepatitis C virus infection in patients with essential mixed cryoglobulinemia, multiple myeloma and chronic lymphocytic leukemia. Pathol Oncol Res. 2001;7(2):135\u20139.","journal-title":"Pathol Oncol Res"},{"issue":"1","key":"14420_CR15","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/hep.21642","volume":"46","author":"M Ulcickas Yood","year":"2007","unstructured":"Ulcickas Yood M, Quesenberry CP Jr., Guo D, Caldwell C, Wells K, Shan J, et al. Incidence of non-Hodgkin\u2019s lymphoma among individuals with chronic hepatitis B virus infection. Hepatology. 2007;46(1):107\u201312.","journal-title":"Hepatology"},{"issue":"4","key":"14420_CR16","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s12185-008-0175-3","volume":"88","author":"V Okan","year":"2008","unstructured":"Okan V, Yilmaz M, Bayram A, Kis C, Cifci S, Buyukhatipoglu H, et al. Prevalence of hepatitis B and C viruses in patients with lymphoproliferative disorders. Int J Hematol. 2008;88(4):403\u20138.","journal-title":"Int J Hematol"},{"issue":"10","key":"14420_CR17","doi-asserted-by":"publisher","first-page":"4296","DOI":"10.1182\/blood.V87.10.4296.bloodjournal87104296","volume":"87","author":"F Silvestri","year":"1996","unstructured":"Silvestri F, Pipan C, Barillari G, Zaja F, Fanin R, Infanti L, et al. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Blood. 1996;87(10):4296\u2013301.","journal-title":"Blood"},{"issue":"3","key":"14420_CR18","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/ajh.1101","volume":"67","author":"P Hausfater","year":"2001","unstructured":"Hausfater P, Cacoub P, Sterkers Y, Thibault V, Amoura Z, Nguyen L, et al. Hepatitis C virus infection and lymphoproliferative diseases: prospective study on 1,576 patients in France. Am J Hematol. 2001;67(3):168\u201371.","journal-title":"Am J Hematol"},{"key":"14420_CR19","doi-asserted-by":"crossref","unstructured":"Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372.","DOI":"10.1136\/bmj.n160"},{"issue":"6","key":"14420_CR20","first-page":"1792","volume":"117","author":"F Marcucci","year":"2011","unstructured":"Marcucci F, Mele A. Hepatitis viruses and non-Hodgkin lymphoma: epidemiology, mechanisms of tumorigenesis, and therapeutic opportunities. Blood J Am Soc Hematol. 2011;117(6):1792\u20138.","journal-title":"Blood J Am Soc Hematol"},{"key":"14420_CR21","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1007\/s00432-012-1279-y","volume":"138","author":"N Becker","year":"2012","unstructured":"Becker N, Schnitzler P, Boffetta P, Brennan P, Foretova L, Maynadi\u00e9 M, et al. Hepatitis B virus infection and risk of lymphoma: results of a serological analysis within the European case\u2013control study Epilymph. J Cancer Res Clin Oncol. 2012;138:1993\u20132001.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"5","key":"14420_CR22","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1111\/apt.15132","volume":"49","author":"TH Su","year":"2019","unstructured":"Su TH, Liu CJ, Tseng TC, Chou SW, Liu CH, Yang HC, et al. Chronic hepatitis B is associated with an increased risk of B-cell non\u2010Hodgkin\u2019s lymphoma and multiple myeloma. Aliment Pharmacol Ther. 2019;49(5):589\u201398.","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"14420_CR23","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","volume":"140","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140(6):883\u201399.","journal-title":"Cell"},{"key":"14420_CR24","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3389\/fimmu.2014.00258","volume":"5","author":"A Schuch","year":"2014","unstructured":"Schuch A, Hoh A, Thimme R. The role of natural killer cells and CD8\u2009+\u2009T cells in hepatitis B virus infection. Front Immunol. 2014;5:258.","journal-title":"Front Immunol"},{"issue":"7","key":"14420_CR25","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/ng.2295","volume":"44","author":"W-K Sung","year":"2012","unstructured":"Sung W-K, Zheng H, Li S, Chen R, Liu X, Li Y, et al. Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma. Nat Genet. 2012;44(7):765\u20139.","journal-title":"Nat Genet"},{"issue":"1","key":"14420_CR26","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/imr.12233","volume":"263","author":"Y Kawano","year":"2015","unstructured":"Kawano Y, Moschetta M, Manier S, Glavey S, G\u00f6rg\u00fcn GT, Roccaro AM, et al. Targeting the bone marrow microenvironment in multiple myeloma. Immunol Rev. 2015;263(1):160\u201372.","journal-title":"Immunol Rev"},{"key":"14420_CR27","doi-asserted-by":"crossref","unstructured":"Liu C-J, Kao J-H, editors. Global perspective on the natural history of chronic hepatitis B: role of hepatitis B virus genotypes A to J. Seminars in liver disease. Thieme Medical; 2013.","DOI":"10.1055\/s-0033-1345716"},{"issue":"4","key":"14420_CR28","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/rmv.1885","volume":"26","author":"A Kramvis","year":"2016","unstructured":"Kramvis A. The clinical implications of hepatitis B virus genotypes and hbeag in pediatrics. Rev Med Virol. 2016;26(4):285\u2013303.","journal-title":"Rev Med Virol"},{"issue":"9","key":"14420_CR29","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1111\/j.1349-7006.2004.tb03256.x","volume":"95","author":"K Matsuo","year":"2004","unstructured":"Matsuo K, Kusano A, Sugumar A, Nakamura S, Tajima K, Mueller NE. Effect of hepatitis C virus infection on the risk of non-Hodgkin\u2019s lymphoma: a meta\u2010analysis of epidemiological studies. Cancer Sci. 2004;95(9):745\u201352.","journal-title":"Cancer Sci"},{"issue":"11","key":"14420_CR30","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1002\/art.22168","volume":"54","author":"D Saadoun","year":"2006","unstructured":"Saadoun D, Resche-Rigon M, Thibault V, Piette JC, Cacoub P. Antiviral therapy for hepatitis C virus\u2013associated mixed cryoglobulinemia vasculitis: a long\u2010term followup study. Arthritis Rheumatism: Official J Am Coll Rheumatol. 2006;54(11):3696\u2013706.","journal-title":"Arthritis Rheumatism: Official J Am Coll Rheumatol"},{"issue":"12","key":"14420_CR31","doi-asserted-by":"publisher","first-page":"4262","DOI":"10.1073\/pnas.0303971101","volume":"101","author":"K Machida","year":"2004","unstructured":"Machida K, Cheng KT-N, Sung VM-H, Shimodaira S, Lindsay KL, Levine AM, et al. Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes. Proc Natl Acad Sci. 2004;101(12):4262\u20137.","journal-title":"Proc Natl Acad Sci"},{"issue":"6","key":"14420_CR32","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3390\/ijms17060803","volume":"17","author":"LE Adinolfi","year":"2016","unstructured":"Adinolfi LE, Rinaldi L, Guerrera B, Restivo L, Marrone A, Giordano M, et al. NAFLD and NASH in HCV infection: prevalence and significance in hepatic and extrahepatic manifestations. Int J Mol Sci. 2016;17(6):803.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"14420_CR33","doi-asserted-by":"publisher","first-page":"djw035","DOI":"10.1093\/jnci\/djw035","volume":"108","author":"P Mahale","year":"2016","unstructured":"Mahale P, Sturgis EM, Tweardy DJ, Ariza-Heredia EJ, Torres HA. Association between hepatitis C virus and head and neck cancers. J Natl Cancer Inst. 2016;108(8):djw035.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"14420_CR34","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1016\/j.jhep.2014.07.027","volume":"61","author":"E Gower","year":"2014","unstructured":"Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H. Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol. 2014;61(1):S45\u201357.","journal-title":"J Hepatol"},{"issue":"1","key":"14420_CR35","doi-asserted-by":"publisher","first-page":"e2025006","DOI":"10.4084\/MJHID.2025.006","volume":"17","author":"EA Martino","year":"2025","unstructured":"Martino EA, Mele G, Vigna E, Morabito F, Gentile M. Refining high-risk multiple myeloma: advancements in genomic, clinical, and prognostic criteria. Mediterranean J Hematol Infect Dis. 2025;17(1):e2025006.","journal-title":"Mediterranean J Hematol Infect Dis"},{"issue":"4","key":"14420_CR36","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1002\/hep.26141","volume":"57","author":"K Mohd Hanafiah","year":"2013","unstructured":"Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013;57(4):1333\u201342.","journal-title":"Hepatology"},{"issue":"1","key":"14420_CR37","first-page":"272","volume":"109","author":"A Rodr\u00edguez-Garc\u00eda","year":"2024","unstructured":"Rodr\u00edguez-Garc\u00eda A, Mennesson N, Hernandez-Ibarburu G, Morales ML, Garderet L, Bouchereau L, et al. Impact of viral hepatitis therapy in multiple myeloma and other monoclonal gammopathies linked to hepatitis B or C viruses. Haematologica. 2024;109(1):272\u201382.","journal-title":"Haematologica"},{"key":"14420_CR38","doi-asserted-by":"crossref","unstructured":"Huang CH, Wu VC, Wang CL, Wu CL, Huang YT, Chang SH. Silymarin synergizes with antiviral therapy in hepatitis B virus-related liver cirrhosis: a propensity score matching multi-institutional study. Int J Mol Sci. 2024;25(6).","DOI":"10.3390\/ijms25063088"},{"issue":"7","key":"14420_CR39","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1200\/JCO.23.00757","volume":"42","author":"DQ Huang","year":"2024","unstructured":"Huang DQ, Hoang JK, Kamal R, Tsai PC, Toyoda H, Yeh ML, et al. Antiviral therapy utilization and 10-year outcomes in resected hepatitis B virus- and hepatitis C virus-related hepatocellular carcinoma. J Clin Oncology: Official J Am Soc Clin Oncol. 2024;42(7):790\u20139.","journal-title":"J Clin Oncology: Official J Am Soc Clin Oncol"},{"issue":"8","key":"14420_CR40","doi-asserted-by":"publisher","first-page":"3034","DOI":"10.1182\/blood-2005-09-3679","volume":"107","author":"F Suarez","year":"2006","unstructured":"Suarez F, Lortholary O, Hermine O, Lecuit M. Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation. Blood. 2006;107(8):3034\u201344.","journal-title":"Blood"},{"issue":"1","key":"14420_CR41","first-page":"19","volume":"109","author":"E O\u2019Donnell","year":"2024","unstructured":"O\u2019Donnell E. Exploring the role of viral hepatitis in plasma cell disorders. Haematologica. 2024;109(1):19\u201320.","journal-title":"Haematologica"},{"issue":"1","key":"14420_CR42","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1159\/000533595","volume":"66","author":"B Mahmud Hussen","year":"2023","unstructured":"Mahmud Hussen B, Noori M, Sayad B, Ebadi Fard Azar M, Sadri Nahand J, Bayat M, et al. New potential MicroRNA biomarkers in human immunodeficiency virus elite controllers, human immunodeficiency virus infections, and coinfections with hepatitis B virus or hepatitis C virus. Intervirology. 2023;66(1):122\u201335.","journal-title":"Intervirology"},{"issue":"4","key":"14420_CR43","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1089\/jir.2024.0195","volume":"45","author":"BS Ulloa","year":"2025","unstructured":"Ulloa BS, Barber-Axthelm I, Berube B, Duthie M, Reed S, Savan R, et al. Synthetic RIG-I-Agonist RNA induces death of hepatocellular carcinoma cells. J Interferon Cytokine Research: Official J Int Soc Interferon Cytokine Res. 2025;45(4):119\u201332.","journal-title":"J Interferon Cytokine Research: Official J Int Soc Interferon Cytokine Res"},{"issue":"6","key":"14420_CR44","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/cld.978","volume":"16","author":"RK Dhiman","year":"2020","unstructured":"Dhiman RK, Premkumar M, Hepatitis C. Virus elimination by 2030: conquering mount improbable. Clin Liver Disease. 2020;16(6):254\u201361.","journal-title":"Clin Liver Disease"},{"issue":"1","key":"14420_CR45","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/bjd\/ljae354","volume":"192","author":"HP Stevens","year":"2024","unstructured":"Stevens HP, Pellacani G, Angus C, El-Jabbour JN. Reflectance confocal microscopy to diagnose malignant melanoma and lentigo maligna in the UK: a single-centre prospective observational trial. Br J Dermatol. 2024;192(1):27\u201335.","journal-title":"Br J Dermatol"},{"issue":"1","key":"14420_CR46","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/CORR.0000000000003161","volume":"483","author":"CJ Anderson","year":"2025","unstructured":"Anderson CJ, Yang H, Parsons J, Ahrens WA, Jagosky MH, Hsu JH, et al. Can a liquid biopsy detect circulating tumor DNA with low-passage whole-genome sequencing in patients with a sarcoma?? A pilot evaluation. Clin Orthop Relat Res. 2025;483(1):39\u201348.","journal-title":"Clin Orthop Relat Res"},{"issue":"2","key":"14420_CR47","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1053\/j.gastro.2013.10.056","volume":"146","author":"Y Okamoto","year":"2014","unstructured":"Okamoto Y, Shinjo K, Shimizu Y, Sano T, Yamao K, Gao W, et al. Hepatitis virus infection affects DNA methylation in mice with humanized livers. Gastroenterology. 2014;146(2):562\u201372.","journal-title":"Gastroenterology"},{"key":"14420_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2164-10-373","volume":"10","author":"X Peng","year":"2009","unstructured":"Peng X, Li Y, Walters K-A, Rosenzweig ER, Lederer SL, Aicher LD, et al. Computational identification of hepatitis C virus associated microRNA-mRNA regulatory modules in human livers. BMC Genomics. 2009;10:1\u201320.","journal-title":"BMC Genomics"},{"issue":"2","key":"14420_CR49","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3390\/v5020439","volume":"5","author":"AV Ivanov","year":"2013","unstructured":"Ivanov AV, Bartosch B, Smirnova OA, Isaguliants MG, Kochetkov SN. HCV and oxidative stress in the liver. Viruses. 2013;5(2):439\u201369.","journal-title":"Viruses"},{"issue":"8","key":"14420_CR50","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nri3862","volume":"15","author":"EJ Wherry","year":"2015","unstructured":"Wherry EJ, Kurachi M. Molecular and cellular insights into T cell exhaustion. Nat Rev Immunol. 2015;15(8):486\u201399.","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"14420_CR51","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/leu.2008.307","volume":"23","author":"A Dispenzieri","year":"2009","unstructured":"Dispenzieri A, Kyle R, Merlini G, Miguel J, Ludwig H, Hajek R, et al. International myeloma working group guidelines for serum-free light chain analysis in multiple myeloma and related disorders. Leukemia. 2009;23(2):215\u201324.","journal-title":"Leukemia"},{"issue":"3","key":"14420_CR52","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1515\/cclm-2023-0591","volume":"62","author":"R Goldis","year":"2024","unstructured":"Goldis R, Kaplan B, Arad M, Dispenzieri A, Dasari S, Kukuy OL, et al. Amino acid sequence homology of monoclonal serum free light chain dimers and tissue deposited light chains in AL amyloidosis: a pilot study. Clin Chem Lab Med. 2024;62(3):464\u201371.","journal-title":"Clin Chem Lab Med"},{"issue":"2","key":"14420_CR53","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1177\/14690667231153616","volume":"29","author":"ZZ Kaya","year":"2023","unstructured":"Kaya ZZ, Serdar M, Aksungar F, Kilercik M, Serteser M, Baykal AT. Rapid detection of serum free light chains by matrix-assisted laser desorption\/ionization time-of-flight mass spectrometry. Eur J Mass Spectrom. 2023;29(2):132\u201340.","journal-title":"Eur J Mass Spectrom"},{"issue":"21","key":"14420_CR54","first-page":"2527","volume":"128","author":"L Arcaini","year":"2016","unstructured":"Arcaini L, Besson C, Frigeni M, Fontaine H, Goldaniga M, Casato M, et al. Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection. Blood J Am Soc Hematol. 2016;128(21):2527\u201332.","journal-title":"Blood J Am Soc Hematol"},{"issue":"12","key":"14420_CR55","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.cmi.2017.06.023","volume":"23","author":"L Sarmati","year":"2017","unstructured":"Sarmati L, Andreoni M, Antonelli G, Arcese W, Bruno R, Coppola N, et al. Recommendations for screening, monitoring, prevention, prophylaxis and therapy of hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic stem cell transplantation\u2014a position paper. Clin Microbiol Infect. 2017;23(12):935\u201340.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"14420_CR56","doi-asserted-by":"publisher","first-page":"HEP03","DOI":"10.2217\/hep-2017-0024","volume":"5","author":"M Colombo","year":"2018","unstructured":"Colombo M, Lleo A. The impact of antiviral therapy on hepatocellular carcinoma epidemiology. Hepatic Oncol. 2018;5(1):HEP03.","journal-title":"Hepatic Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14420-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14420-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14420-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T11:03:37Z","timestamp":1749035017000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14420-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,4]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14420"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14420-5","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,4]]},"assertion":[{"value":"23 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"998"}}